Glenmark Pharmaceuticals Launches GLIPIQ® (Semaglutide) in India, Setting Affordability Benchmark for GLP-1 Therapy
Glenmark Pharmaceuticals announced the launch of GLIPIQ® (semaglutide) in India for Type 2 Diabetes Mellitus (T2DM) management. This launch…